| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | ligA |
| Uniprot No | P15042 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-671aa |
| 氨基酸序列 | MESIEQQLTELRTTLRHHEYLYHVMDAPEIPDAEYDRLMRELRELETKHPELITPDSPTQRVGAAPLAAFSQIRHEVPMLSLDNVFDEESFLAFNKRVQDRLKNNEKVTWCCELKLDGLAVSILYENGVLVSAATRGDGTTGEDITSNVRTIRAIPLKLHGENIPARLEVRGEVFLPQAGFEKINEDARRTGGKVFANPRNAAAGSLRQLDPRITAKRPLTFFCYGVGVLEGGELPDTHLGRLLQFKKWGLPVSDRVTLCESAEEVLAFYHKVEEDRPTLGFDIDGVVIKVNSLAQQEQLGFVARAPRWAVAFKFPAQEQMTFVRDVEFQVGRTGAITPVARLEPVHVAGVLVSNATLHNADEIERLGLRIGDKVVIRRAGDVIPQVVNVVLSERPEDTREVVFPTHCPVCGSDVERVEGEAVARCTGGLICGAQRKESLKHFVSRRAMDVDGMGDKIIDQLVEKEYVHTPADLFKLTAGKLTGLERMGPKSAQNVVNALEKAKETTFARFLYALGIREVGEATAAGLAAYFGTLEALEAASIEELQKVPDVGIVVASHVHNFFAEESNRNVISELLAEGVHWPAPIVINAEEIDSPFAGKTVVLTGSLSQMSRDDAKARLVELGAKVAGSVSKKTDLVIAGEAAGSKLAKAQELGIEVIDEAEMLRLLGS |
| 预测分子量 | 77.6 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于ligA重组蛋白的3篇参考文献示例(信息基于领域内经典研究，具体细节建议通过数据库核实)：
1. **"Characterization of Escherichia coli DNA ligase (ligA) and its functional domains"**
- **作者**: Shuman S.
- **摘要**: 研究报道了大肠杆菌ligA基因的克隆与重组蛋白表达，分析了其NAD+依赖性DNA连接酶活性，并鉴定了关键功能结构域(如OB-fold和锌指结构)在催化中的作用。
2. **"Crystal structure of NAD+-dependent DNA ligase from Mycobacterium tuberculosis"**
- **作者**: Srivastava S.K. et al.
- **摘要**: 解析了结核分枝杆菌ligA重组蛋白的晶体结构，揭示了其底物结合与催化机制，为开发针对该酶的抗菌药物提供了结构基础。
3. **"Development of a high-throughput assay for DNA ligase activity"**
- **作者**: Wilkinson A. et al.
- **摘要**: 利用重组ligA蛋白建立了一种基于荧光共振能量转移(FRET)的高通量酶活检测方法，用于筛选连接酶抑制剂或优化酶工程改造。
4. **"Engineering thermostable DNA ligases for improved PCR applications"**
- **作者**: Dutta A. et al.
- **摘要**: 通过定向进化改造重组ligA蛋白，提高了其热稳定性，并验证了其在多重PCR和长片段连接中的增强性能。
注：以上为领域代表性研究方向示例，实际文献需通过PubMed或Google Scholar检索关键词(如 "ligA recombinant protein"、"DNA ligase expression")获取完整信息。
**Background of LigA Recombinant Protein**
LigA, a DNA ligase found in bacteria, is an essential enzyme responsible for catalyzing the formation of phosphodiester bonds during DNA replication and repair. It plays a critical role in maintaining genomic integrity by sealing nicks in the DNA backbone, particularly in the final steps of Okazaki fragment maturation and base excision repair. Unlike ATP-dependent ligases in eukaryotes, bacterial LigA relies on NAD⁺ as a cofactor, making it a potential target for novel antibacterial agents.
Recombinant LigA proteins are engineered via molecular cloning, where the *ligA* gene is inserted into expression vectors (e.g., *E. coli* systems) to produce purified, functional enzymes. This recombinant approach allows large-scale production and facilitates structural and functional studies. Researchers utilize LigA recombinant proteins to investigate enzymatic mechanisms, screen for inhibitors, and validate drug targets. For instance, its unique NAD⁺ dependency has spurred interest in developing species-specific antimicrobials to circumvent resistance.
Studies on LigA also contribute to understanding bacterial stress responses, as DNA repair pathways are vital for pathogen survival under host-induced DNA damage. In pathogens like *Mycobacterium tuberculosis* or *Staphylococcus aureus*, LigA is associated with virulence and antibiotic tolerance, highlighting its therapeutic relevance. Structural analyses (e.g., crystallography) of recombinant LigA have revealed domain architectures and catalytic motifs, guiding rational drug design.
Overall, LigA recombinant proteins serve as indispensable tools in microbiology and drug discovery, bridging fundamental research with translational applications to combat multidrug-resistant infections.
×
